As of Oct 21
| -0.16 / -2.43%|
The 7 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +40.19% increase from the last price of 6.42.
The current consensus among 8 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.